NICE, France, July 11, 2016 -- OPTrust is investing in an equity portfolio that is benchmarked to the Scientific Beta Developed Multi-Beta Multi-Strategy Relative Volatility (90%) Solution.
One of the characteristics of traditional defensive strategies such as Minimum or Low Volatility is that they are concentrated in low volatility or low beta stocks. Therefore, while over a very long period these defensive strategies outperform cap-weighted indices, over the short term, in a bull market, they could seriously underperform.
It is in this context that researchers from EDHEC-Risk Institute and ERI Scientific Beta have developed a new approach in terms of multi-factor dynamic defensive strategies. The Scientific Beta Multi-Beta Multi-Strategy relative volatility solution indices are no longer exposed to low volatility factors alone but obtain a significant reduction in portfolio volatility through factor diversification. Moreover, these new strategies have a variable defensive bias, which corresponds to dynamic allocation between smart factor indices based on market volatility. It involves ramping up the defensive profile of the strategy when high market volatility makes it necessary. This new approach to defensive smart beta provides not only excess return but also a significant reduction in volatility over the long term compared with cap-weighted benchmarks, while at the same time outperforming in bull markets.
The benefits of dynamic allocation are even more evident in extreme bull markets relative to low volatility strategies, with higher probabilities of outperformance in the short- and medium-terms and a lower maximum relative drawdown.
Noël Amenc, CEO of ERI Scientific Beta, said, "The beauty of ERI Scientific Beta's dynamic defensive solution is that it is defensive when needed. This is reflected in the dynamic nature of the approach. Unlike most defensive approaches on the market, our approach does not focus on a low volatility/low beta factor, but is a diversification approach based on the flagship Scientific Beta Multi-Beta Multi-Strategy indices."
James Davis, CIO of OPTrust, said, "We worked closely with the ERI Scientific Beta team to evaluate different smart beta strategies that aligned with our Member Driven Investing investment objectives. The Multi-Beta, Multi-Strategy solution we chose provides for downside risk mitigation. By employing a dynamic strategy that reduces volatility in times of market stress, we can be more comfortable with our overall equity exposure."
As part of its policy of transferring know-how to the industry, EDHEC-Risk Institute has set up ERI Scientific Beta. ERI Scientific Beta is an original initiative which aims to favour the adoption of the latest advances in smart beta design and implementation by the whole investment industry. Its academic origin provides the foundation for its strategy: offer, in the best economic conditions possible, the smart beta solutions that are most proven scientifically with full transparency of both the methods and the associated risks.
ERI Scientific Beta, 1 George Street, #07-02, Singapore 049145. For further information, please contact: [email protected], Web: www.scientificbeta.com.
Press_release_OPTrust_institutional_mandate http://hugin.info/157174/R/2027627/753586.pdf
HUG#2027627


FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 



